MeSH tree: C06.405.469.432
For patients with moderate-to-severe Crohn's disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for endoscopic remission at week 48, according to a study published in the ...
Jul 18, 2024
0
43
Subcutaneous delivery of an anti-TNF inhibitor drug improved remission rates in patients with moderate-to-severe Crohn's disease and ulcerative colitis, according to recent phase 3 clinical trial results published in the ...
Jul 16, 2024
0
46
Scientists at Nottingham Trent University, the University of Nottingham, Stanford University and the University of California and Cedars-Sinai Medical Center, Los Angeles, have found that the molecule "HNF4A" suppresses pancreatic ...
Jul 15, 2024
0
80
Dealing with chronic conditions like Crohn's disease and ulcerative colitis can be challenging and sometimes embarrassing. Inflammatory bowel disease (IBD) can cause diarrhea, stomach pain, weight loss and other symptoms. ...
Jul 15, 2024
0
27
A cross-institutional research team led by the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel cinnamaldehyde-based prodrug nanomedicine by utilizing cinnamaldehyde, a common food additive, ...
Jul 12, 2024
0
74
A new method of precisely targeting troublesome cells for death using light could unlock new understanding of and treatments for cancer and inflammatory diseases, University of Illinois Urbana-Champaign researchers report.
Jul 1, 2024
0
42
Tampere University researchers developed a method to map mechanistic connections between diseases, revealing deeper associations beyond traditional classifications based on affected organs and symptoms. This multi-dimensional ...
Jun 28, 2024
0
124
Remarkable new research by a University of Virginia undergraduate may help explain recurrent Crohn's disease in children and open the door to new ways to treat or even cure the devastating condition. The work is published ...
Jun 28, 2024
0
385
A new study has illuminated the connection between inflammatory bowel disease (IBD) and lipid profile. IBD is a chronic condition that causes inflammation in the intestines. Abnormal lipid factor levels such as cholesterol ...
Jun 27, 2024
0
40
A new study by investigators from Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham, reveals that particular strains of gut bacteria are linked to inflammatory bowel disease (IBD), a condition ...
Jun 25, 2024
0
108
